Admission Date:  [**2199-12-13**]              Discharge Date:   [**2199-12-24**]  Date of Birth:  [**2132-6-19**]             Sex:   F  Service: CARDIOTHORACIC  Allergies: Avelox / Codeine / Erythromycin / Glucophage / Glipizide / Penicillins / Sulfa (Sulfonamides) / Tetracycline / Shellfish / Aspartame  Attending:[**First Name3 (LF) 1505**] Chief Complaint: SOB and angina  Major Surgical or Invasive Procedure: cabg x3/MV repair  [**2199-12-16**] (LIMA to LAD, SVG to OM1, SVG to OM2, 28 mm CE annuloplasty band)  History of Present Illness: 67 yo female presented to OSH with chest pressure and SOB [**12-11**] and ruled in for NSTEMI.
Cath there revealed 90% LAD lesions, CX 90%, OM 50%, RCA 40% with EF 30% Significant MR also noted.
lipids CHF diastolic ( EF 50%) NIDDM retinopathy remote asthma  PSH: appy, cholecystectomy, cataract [**Doctor First Name **], fxs ankle and arm   Social History: no ETOH abuse no current tobacco use  Family History: sister with premature CAD/cabg father with fatal MI at 59  Physical Exam: 95% on 2L NC 61.5 "   79.9 kg T 100.3, 122/64    ST 110  RR 20 NAD, and oriented appropriately NCAT, PERRL, EOMI,anicteric neck supple with JVP to jaw RRR S1 S2  no m/r/g bibasilar rales soft, NT, ND,no abd.
fem/DP/PTs , no bruits  Pertinent Results: [**2199-12-24**] 07:10AM BLOOD WBC-18.0* RBC-3.75* Hgb-11.1* Hct-33.3* MCV-89 MCH-29.7 MCHC-33.4 RDW-14.5 Plt Ct-547* [**2199-12-23**] 03:44AM BLOOD WBC-20.9* RBC-3.87* Hgb-11.4* Hct-33.4* MCV-86 MCH-29.4 MCHC-34.0 RDW-14.4 Plt Ct-436 [**2199-12-22**] 04:16AM BLOOD WBC-18.7* RBC-3.77* Hgb-11.4* Hct-33.2* MCV-88 MCH-30.3 MCHC-34.4 RDW-14.5 Plt Ct-368 [**2199-12-24**] 07:10AM BLOOD Plt Ct-547* [**2199-12-23**] 09:16AM BLOOD PT-19.8* INR(PT)-1.8* [**2199-12-22**] 04:16AM BLOOD PT-17.4* PTT-26.3 INR(PT)-1.6* [**2199-12-21**] 02:43AM BLOOD PT-17.4* INR(PT)-1.6* [**2199-12-20**] 02:20AM BLOOD PT-17.3* PTT-27.4 INR(PT)-1.6* [**2199-12-24**] 07:10AM BLOOD Glucose-154* UreaN-12 Creat-0.5 Na-137 K-3.9 Cl-97 HCO3-31 AnGap-13  [**Hospital1 18**] ECHOCARDIOGRAPHY REPORT  [**Known lastname 76240**], [**Known firstname **]       [**Hospital1 18**] [**Numeric Identifier 76241**]Portable TTE (Complete) Done [**2199-12-18**] at 1:23:17 PM      FINAL Referring Physician     [**Name9 (PRE) **] Information [**Name9 (PRE) **], [**First Name3 (LF) **] R. Division of Cardiothoracic [**Doctor First Name **] [**Hospital Unit Name 4081**] [**Location (un) 86**], [**Numeric Identifier 718**]  Status: Inpatient DOB: [**2132-6-19**] Age (years): 67 F  Hgt (in): 62 BP (mm Hg): 116/54  Wgt (lb): 210 HR (bpm): 92  BSA (m2): 1.95 m2 Indication: H/O cardiac surgery.
ICD-9 Codes: 423.9, V43.3, 424.0 Test Information Date/Time: [**2199-12-18**] at 13:23    Interpret MD: [**Initials (NamePattern4) **] [**Last Name (NamePattern4) **] [**Last Name (NamePattern1) **], MD Test Type: Portable TTE (Complete) Son[**Name (NI) 930**]: [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **], RDCS Doppler: Full Doppler and color Doppler Test Location: West SICU/CTIC/VICU Contrast: None Tech Quality: Suboptimal Tape #: 2007W046-1:02 Machine: Vivid [**7-21**] Echocardiographic Measurements Results  Measurements  Normal Range Left Atrium - Long Axis Dimension:  *4.6 cm  <= 4.0 cm Left Ventricle - Septal Wall Thickness:  1.0 cm  0.6 - 1.1 cm Left Ventricle - Inferolateral Thickness:  0.9 cm  0.6 - 1.1 cm  Left Ventricle - Diastolic Dimension:  4.3 cm  <= 5.6 cm Left Ventricle - Systolic Dimension:  3.1 cm Left Ventricle - Fractional Shortening:  *0.28  >= 0.29 Left Ventricle - Ejection Fraction:  40% to 45%  >= 55% Aorta - Sinus Level:  2.4 cm  <= 3.6 cm Aorta - Ascending:  3.0 cm  <= 3.4 cm Aortic Valve - Peak Velocity:  1.6 m/sec  <= 2.0 m/sec Mitral Valve - E Wave:  1.6 m/sec Mitral Valve - A Wave:  0.8 m/sec Mitral Valve - E/A ratio:  2.00 Mitral Valve - E Wave deceleration time:  244 ms  140-250 ms TR Gradient (+ RA = PASP):  *35 to 43 mm Hg  <= 25 mm Hg  Findings This study was compared to the prior study of [**2199-12-14**].
GENERAL COMMENTS: Suboptimal image quality - poor echo windows.
Left ventricular wall thicknesses and cavity size are normal.
Compared with the prior study (images reviewed) of [**2199-12-14**] , there is now a mitral valvuloplasty ring in position.
Brief Hospital Course: Admitted [**12-13**]  from EMMC, and pre-op workup completed over the weekend.
Cleared for discharge to rehab on POD #8 Target INR 2.0-2.5 for A fib.
Warfarin 1 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily): check INR [**12-26**] and PRN, and dose accordingly.
